Differential alterations in plasma colony-stimulating factor concentrations after coronary artery bypass graft surgery with extracorporeal circulation

Cytokine

Volumn 13, Issue 5, 2001, Pages 314-316

  Denizot, Yves ^a   Karoutsos, S ^b   Nathan, Nathalie ^b  

^a UNIVERSITY OF LIMOGES   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Coronary artery bypass graft; Extracorporeal circulation; G CS; GM CSF; Inflammation; M CSF

Indexed keywords

APROTININ; COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR 1; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; EXTRACORPOREAL CIRCULATION; HUMAN; INFLAMMATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WEANING;

EID: 0035819766     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2000.0834     Document Type: Article

References (15)

1. Plasma leukemia inhibitory factor, interleukin-6 and soluble interleukin-6 receptor levels during cardiopulmonary bypass with extracorporeal circulation
2. Are lipid mediators implicated in the production of pro- and anti-inflammatory cytokines during cardiopulmonary bypass graft with extracorporeal circulation?
3. Interleukin-10 and interleukin-1 receptor antagonists increase during cardiac surgery
4. Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure
5. Inflammatory response to cardiopulmonary bypass
6. Plasma interleukin-4, interleukin-10, and interleukin-13 concentrations and complications after coronary artery bypass graft surgery
7. M-CSF: Haematopoietic growth factor or inflammatory cytokine?
8. Anti-inflammatory effect of granulocyte colony-stimulating factor
9. The effect of granulocyte-macrophage colony-stimulating factor on myeloid cells and its clinical applications
10. Thrombocytopenia in the sepsis syndrome: Role of hemophagocytosis and macrophage colony-stimulating factor
11. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: Relation to disease severity, multiple organ dysfunction, and mortality
12. Elevated plasma levels of interleukin-6, interleukin-8, and granulocyte colony-stimulating factor during and after major abdominal surgery
13. Granulocyte colony-stimulating factor (G-CSF) serum levels in surgical intensive care patients
14. Recombinant human granulocyte colony-stimulating factor attenuates inflammatory responses in septic patients with neutropenia
15. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass